<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01945684</url>
  </required_header>
  <id_info>
    <org_study_id>DW_DWP450002</org_study_id>
    <nct_id>NCT01945684</nct_id>
  </id_info>
  <brief_title>A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Daewoong Pharmaceutical Co. LTD.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Daewoong Pharmaceutical Co. LTD.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: This study is a Randomized, Double Blind, Multi-center, Active Drug Controlled,
      Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in
      Treatment of Post Stroke Upper Limb(wrist, finger, elbow, thumb)Spasticity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change in MAS(Modified Ashworth Scale)grade for Wrist flexor</measure>
    <time_frame>at 4 week</time_frame>
    <description>The change in MAS (Modified Ashworth Scale) grade from baseline at week 4 for wrist flexor muscle tone</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">197</enrollment>
  <condition>Spasticity</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Botulinum toxin type A (DWP450)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DWP450: Botulinum toxin type A</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Botulinum toxin type A (Botox®)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Botox®: Botulinum toxin type A</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum toxin type A</intervention_name>
    <description>Maximum dose 360 U</description>
    <arm_group_label>Botulinum toxin type A (DWP450)</arm_group_label>
    <arm_group_label>Botulinum toxin type A (Botox®)</arm_group_label>
    <other_name>Assigned Interventions</other_name>
    <other_name>Experimental: DWP450</other_name>
    <other_name>Botulinum toxin type A Drug: Botulinum toxin type A</other_name>
    <other_name>Active Comparator: Botox®</other_name>
    <other_name>Botulinum Toxin type A Drug: Botulinum Toxin type A (Botox®)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female adult patients

          2. ≥ 6 weeks since the last stroke

        Exclusion Criteria:

        1.Patients with diagnosed neuromuscular disorders such as Lamber-Eaton syndrome, myasthenia
        gravis, or amyotrophic lateral sclerosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>SMG-SNU Boramae Medical Center, 41, Borame-Gill, Dong Gjak-Gu</name>
      <address>
        <city>Seoul</city>
        <zip>156-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 16, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 18, 2013</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Muscle Spasticity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

